Trial Profile
Quetiapine augmentation in severe obsessive compulsive disorder (OCD) - Pilot study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Oct 2008
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Obsessive-compulsive disorders
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 01 Oct 2008 Results published in Journal of Clinical Psychopharmacology.
- 17 Dec 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 10 Oct 2006 Status change